Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2022

View Archived Issues

CD22 aberrant splicing confers resistance to therapy in B-ALL

Dysregulation of the tRNA synthetase modulator NOTCH1 behind T-ALL pathogenesis

Discovery of novel hybrid compounds as antitubercular agents

TuA-derived hPep elicits long-term anticancer immunity in mice

Leo Pharma discloses IL-17 modulators

Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics

Anaxis Pharma patents MLKL inhibitors

Abbisko Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Betta Pharmaceuticals synthesizes new HIF-2alpha inhibitors

Wigen Biomedicine Technology presents new CDK inhibitors

CD6-ALCAM pathway is a therapeutic target in SLE

Methamphetamine harnessed for good in BBB transport

REVTx-99 demonstrates in vitro antiviral activity against SARS-CoV-2

PostEra and Pfizer expand strategic collaboration

VCAM-1-targeting polyelectrolyte complex enhances therapeutic efficacy of miR-92a inhibitors in vivo

Dren Bio and Pfizer collaborate to discover and develop bispecific antibodies for cancer

ABL and Sanofi enter collaboration and license agreement for ABL-301

G3PP is a therapeutic target for age-related metabolic diseases

Neogene licenses portfolio of TCRs targeting KRAS and TP53 mutations from NCI

A simple method for the synthesis of isoxazole derivatives with in vitro antitumor activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...